Ciliary neurotrophic factor as a potential biomarker of cerebral pathologies

Capa

Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Ciliary neurotrophic factor (CNTF) is a pluripotent neurotrophic factor with high neuroprotective potential, a neurocytokine that has demonstrated potential in the therapy of neurodegenerative, psychiatric and metabolic diseases. Preclinical data support the general concept of its potential neuroprotective and trophic effects, and recent clinical data support the potential role of CNTF in the treatment of neurodegeneration and obesity. A number of data indicate the involvement of CNTF in stress reactivity and the pathogenesis of affective disorders. Data from studies of CNTF levels in invasive (blood) and non-invasive (tears) human biomaterials suggest the possibility of its use as a biomarker for certain brain diseases, although more research is needed to confirm this.

Texto integral

Acesso é fechado

Sobre autores

A. Gudkova

Moscow Research and Clinical Center for Neuropsychiatry, Moscow Healthcare Department

Autor responsável pela correspondência
Email: gudkov_ann@mail.ru
Rússia, Moscow

Bibliografia

  1. Guo H., Chen P., Luo R., Zhang Y., Xu X., Gou X. // Protein Pept. Lett. 2022. V. 29. P. 815–828. doi: 10.2174/0929866529666220905105800.
  2. Stansberry W.M., Pierchala B.A. // Front. Mol. Neurosci. 2023. V. 16. 1238453. doi: 10.3389/fnmol.2023.1238453.
  3. Pasquin S., Sharma M., Gauchat J.F. // Cytokine Growth Factor Rev. 2015. V. 26. P. 507–515. doi: 10.1016/j.cytogfr.2015.07.007.
  4. Fuhrmann S., Grabosch K., Kirsch M., Hofmann H.D. // J. Comp. Neurol. 2003. V. 461. P. 111–122. doi: 10.1002/cne.10701.
  5. Rose-John S. //Cold Spring Harb. Perspect. Biol. 2018. V. 10. a028415. doi: 10.1101/cshperspect.a028415.
  6. Pasquin S., Sharma M., Gauchat J.F. // Cytokine. 2016. V. 82. P. 122–124. doi: 10.1016/j.cyto.2015.12.019.
  7. Neet K.E., Campenot R.B. // Cell. Mol. Life Sci. 2001. V. 58. P. 1021–1035. doi: 10.1007/PL00000917.
  8. Acheson A., Lindsay R.M. // Seminars in Neuroscience.1994. V. 6. P. 333–341. https://doi.org/10.1006/smns.1994.1042.
  9. Fargali S., Sadahiro M., Jiang C., Frick A.L., Indall T., Cogliani V., Welagen J., Lin W.J. Salton S.R. // J. Mol. Neurosci. 2012. V. 48. P. 654–9. doi: 10.1007/s12031-012-9790-9.
  10. Jablonka S., Dombert B., Asan E., Sendtner M. // J. Anat. 2014. V. 224. P. 3–14. doi: 10.1111/joa.12097.
  11. Emerich D.F., Thanos C.G. // Curr. Gene Ther. 2006. V. 6. P. 147–59. doi: 10.2174/156652306775515547.
  12. Zhou Y., Zhai S., Yang W. // Zhonghua Er Bi Yan Hou Ke Za Zhi. 1999. V. 34. P. 150–3. PMID: 12764805.
  13. Sleeman M.W., Anderson K.D., Lambert P.D., Yancopoulos G.D., Wiegand S.J. // Pharm. Acta. Helv. 2000. V. 74. P. 265–272. doi: 10.1016/s0031-6865(99)00050-3.
  14. Buzas B., Symes A.J., Cox B.M. // J. Neurochem. 1999. V. 72. P. 1882–9. doi: 10.1046/j.1471-4159.1999.0721882.x
  15. Fantuzzi G., Benigni F.M., Sironi M., Conni M., Carelli L., et al. // Cytokine. 1995. V. 7. P. 150–156.
  16. Hudgins S.N., Levison S.W. // Exp Neurol. 1998. V. 150. P. 171–182. doi: 10.1006/exnr.1997.6735.
  17. Mori M., Jefferson J.J., Hummel M., Garbe D.S. // J. Neurosci. 2008. V. 28. P. 5867–5869. doi: 10.1523/JNEUROSCI.1782-08.2008.
  18. Pierce R.C., Bari A.A. // Rev. Neurosci. 2001. V. 12. P. 95–110. doi: 10.1515/revneuro.2001.12.2.95.
  19. Vergara C., Ramirez B. // Brain. Res. Brain. Res. Rev. 2004. V. 47. P. 161–173. doi: 10.1016/j.brainresrev.2004.07.010.
  20. Marques M.J., Neto H.S. // Neurosci. Lett. 1997. V. 234. P. 43–46. doi: 10.1016/s0304-3940(97)00659-9.
  21. Kumon Y., Sakaki S., Watanabe H., Nakano K., Ohta S., Matsuda S., Yoshimura H. Sakanaka M. // Neurosci. Lett. 1996. V. 206. P. 141–144. doi: 10.1016/s0304-3940(96)12450-2.
  22. Li W., Wei D., Zhu Z., Xie X., Zhan S., Zhang R., Zhang G., Huang L. // Front. Aging Neurosci. 2021. V. 13. 587403. doi: 10.3389/fnagi.2020.587403.
  23. Garcia P., Youssef I., Utvik J.K., Florent-Béchard S., Barthélémy V., et al. // J. Neurosci. 2010. V. 30. P. 7516–7527. doi: 10.1523/JNEUROSCI.4182-09.2010.
  24. Blanchard J., Wanka L., Tung Y.C., Cárdenas-Aguayo Mdel C., LaFerla F.M., Iqbal K., Grundke-Iqbal I. // Acta Neuropathol. 2010. V. 120. P. 605–621. doi: 10.1007/s00401-010-0734-6.
  25. Peruga I., Hartwig S., Merkler D., Thöne J., Hovemann B., Juckel G., Gold R., Linker R.A. Behav. Brain Res. 2012. V. 229. P. 325–332. doi: 10.1016/j.bbr.2012.01.020.
  26. Jia C., Brown R.W., Malone H.M., Burgess K.C., Gill, W.D. Keasey M.P., Hagg T. // Psychoneuroendocrinology. 2019. V. 100. P. 96–105. doi: 10.1016/j.psyneuen.2018.09.038.
  27. Jia C., Drew Gill W., Lovins C., Brown R.W., Hagg T. // Female-specific role of ciliary neurotrophic factor in the medial amygdala in promoting stress responses. Neurobiol. Stress. 2022. V. 17. 100435. doi: 10.1016/j.ynstr.2022.100435.
  28. Jia C., Gill W.D., Lovins C., Brown R.W., Hagg T. // Astrocyte focal adhesion kinase reduces passive stress coping by inhibiting ciliary neurotrophic factor only in female mice. Neurobiol. Stress. 2024. V. 30. 100621. doi: 10.1016/j.ynstr.2024.100621.
  29. Alpár A., Zahola P., Hanics J., Hevesi Z., Korchynska S., et al. // Hypothalamic CNTF volume transmission shapes cortical noradrenergic excitability upon acute stress. EMBO J. 2018. V. 37. e100087. doi: 10.15252/embj.2018100087.
  30. Girotti M, Silva JD, George CM, Morilak DA. // Ciliary neurotrophic factor signaling in the rat orbitofrontal cortex ameliorates stress-induced deficits in reversal learning. Neuropharmacology. 2019. V. 160. 107791. doi: 10.1016/j.neuropharm.2019.107791.
  31. Mizushige T., Nogimura D., Nagai A., Mitsuhashi H., Taga Y., Kusubata M., Hattori S., Kabuyama Y. // J. Nutr. Sci. Vitaminol. (Tokyo). 2019. V. 65. P. 251–257. doi: 10.3177/jnsv.65.251.
  32. Grünblatt E., Hu P.E., Bambula M., Zehetmayer S., Jungwirth S., Tragl K.H., Fischer P., and Riederer P. // J. Affect. Disord. 2006. V. 96. P. 111–116. doi: 10.1016/j.jad.2006.05.008.
  33. Druzhkova T., Pochigaeva K., Yakovlev A., Kazimirova E., Grishkina M., Chepelev A., Guekht A., Gulyaeva N. // Metab. Brain. Dis. 2019. V. 34. P. 621–629. doi: 10.1007/s11011-018-0367-3.
  34. Duff E., Baile C.A. // Nutr. Rev. 2003. V. 61. P. 423–426. doi: 10.1301/nr.2003.dec.423–426.
  35. Anderson K.D., Lambert P.D., Corcoran T.L., Murray J.D., Thabet K.E., Yancopoulos G.D., Wiegand S.J. // J. Neuroendocrinol. 2003. V. 15. P. 649–660. doi: 10.1046/j.1365-2826.2003.01043.x.
  36. Roth S.M., Metter E.J., Lee M.R., Hurley B.F., Ferrell R.E. // J. APl. Physiol. 2003. V. 95. P. 1425–1430. doi: 10.1152/jaPlphysiol.00516.2003.
  37. Matthews V.B., Febbraio M.A. // J. Mol. Med. (Berl). 2008. V. 86. P. 353–361. doi: 10.1007/s00109-007-0286-y.
  38. Allen T.L., Matthews V.B., Febbraio M.A. // Handb. Exp. Pharmacol. 201. V. 203. P. 179–199. doi: 10.1007/978-3-642-17214-4_9.
  39. Vavilina I.S., Shpak A.A., Druzhkova T.A., Guekht A.B., Gulyaeva N.V. // Neurochem. J. 2023. V. 17. P. 702–714. https://doi.org/10.1134/S1819712423040268
  40. Shpak A.A., Guekht A.B., Druzhkova T.A., Kozlova K.I., Gulyaeva N.V. // Mol. Vis. 2017. V. 17. P. 799–809. PMID: 29225456.
  41. Shpak A., Guekht A., Druzhkova T., Rider F., Gudkova A., Gulyaeva N. // Neurol. Sci. 2022. V. 43. P. 493–498. doi: 10.1007/s10072-021-05338-4.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Russian Academy of Sciences, 2024